View Full Version : ImmuPharma Announces Final Results Of PhaseIIb Study Of LUPUZOR? In Lupus

11-28-2009, 11:18 PM
ImmuPharma PLC announced the final results from a Phase IIb trial of LUPUZOR? in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor? administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.

More... (http://www.medicalnewstoday.com/articles/171853.php)

11-29-2009, 08:29 PM
Lupuzor has shown that it modulates, through a unique mechanism, a specific subset of CD4 T cells which play a critical role in the physiopathology of Lupus. There is currently no cure for Lupus and most of the existing medications only treat the symptoms whereas Lupuzor has the potential to produce remission of the disease in a substantial proportion of patients.
On October 21, 2008, ImmuPharma PLC, the specialist drug discovery and development company, announced in a press release that the Lupuzor patent was approved in Japan and Australia and received notice of allowance from the US Patent Office!!

If this drug can, indeed, produce remission..then it will be revolutionary in the treatment of Lupus!

Peace and Blessings

12-01-2009, 03:29 PM
WOW...thank you so much for the information. I will discuss this with my doctor at my next appt. thank you for sharing this information